Related Experiment Video
Updated: Jul 18, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Stability of U-10 and U-50 dilutions of insulin lispro
M P Stickelmeyer1, C J Graf, B H Frank
1Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. stickelmeyer_mary_P@lilly.com
Background:
Insulin lispro, a rapid acting analog of human insulin, has been shown to be useful in the treatment of children with diabetes. However, lower concentrations of this insulin may be needed to facilitate optimal clinical use. Therefore, the stability of insulin lispro when diluted with an appropriate diluent was evaluated.
Methods:
Insulin lispro (U-100, 100 U/mL) was diluted with sterile Neutral Protamine Hagedorn (NPH) diluent to U-10 and U-50. After storage for 7, 14, 21, 28, and 32 days at 5 degrees C and 30 degrees C, the diluted insulins were analyzed by high-performance liquid chromatography (HPLC) to determine potency, purity, polymer, and preservative (metacresol or phenol) content in addition to physical appearance and pH determinations. Microbiological testing for preservative effectiveness was performed on the U-10 and U-50 solutions after 32 days at both temperatures.
Results:
U-10 and U-50 dilutions of insulin lispro stored at 5 degrees C and 30 degrees C maintained potency and purity throughout the 32-day testing period. Additionally, both control and diluted vials maintained antimicrobial effectiveness.
Conclusion:
Insulin lispro when diluted with the appropriate diluent demonstrates acceptable stability when stored at 5 degrees C and 30 degrees C for a period of 32 days.
Related Concept Videos
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Production of Pharmaceuticals

